Chronic melatonin consumption prevents obesity-related metabolic abnormalities and protects the heart against myocardial ischemia and reperfusion injury in a prediabetic model of diet-induced obesity

Journal of Pineal Research

Volumn 50, Issue 2, 2011, Pages 171-182

  Nduhirabandi, Frederic ^a   Du Toit, Eugene F ^b   Blackhurst, Dee ^c   Marais, David ^c   Lochner, Amanda ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

antioxidant; cardioprotection; diet induced obesity; insulin resistance; melatonin; myocardial ischemia reperfusion injury; prediabetic

Indexed keywords

DRINKING WATER; GLUCOSE TRANSPORTER 4; INSULIN; MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 42; MITOGEN ACTIVATED PROTEIN KINASE 44; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMETRY; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; CONVALESCENCE; DIETARY INTAKE; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; LONG TERM CARE; MALE; METABOLIC PARAMETERS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; MALE; MELATONIN; MYOCARDIAL REPERFUSION INJURY; OBESITY; PREDIABETIC STATE; RATS; RATS, WISTAR;

EID: 79951667271     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2010.00826.x     Document Type: Article

References (76)

1. Kelly T, Yang W, Chen CS, Reynolds K, He J,. Global burden of obesity in 2005 and projections to 2030. Int J Obes 2008; 32: 1431-1437.
2. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK,. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic Obesity 2008; 16: 2323-2330.
3. Wong C, Marwick TH,. Obesity cardiomyopathy: diagnosis and therapeutic implications. Nat Clin Pract Cardiovasc Med 2007; 4: 480-490. (Pubitemid 47321548)
4. Chess DJ, Stanley WC,. Role of diet and fuel overabundance in the development and progression of heart failure. Cardiovasc Res 2008; 79: 269-278. (Pubitemid 351951607)
5. Evans JL, Goldfine ID, Maddux BA, Grodsky GM,. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002; 23: 599-622. (Pubitemid 35191625)
6. Van Gaal LF, Mertens IL, De Block CE,. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444: 875-880. (Pubitemid 46028447)
7. Dhalla NS, Temsah RM, Netticadan T,. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18: 655-673. (Pubitemid 30406736)
8. Ferrari R, Guardigli G, Mele D, Percoco GF, Ceconi C, Curello S,. Oxidative stress during myocardial ischaemia and heart failure. Curr Pharm Des 2004; 10: 1699-1711. (Pubitemid 38559780)
9. Sethi R, Takeda N, Nagano M, Dhalla NS,. Beneficial effects of vitamin E treatment in acute myocardial infarction. J Cardiovasc Pharmacol Ther 2000; 5: 51-58. (Pubitemid 30082873)
10. Abe M, Takiguchi Y, Ichimaru S, Tsuchiya K, Wada K,. Comparison of the protective effect of N-acetylcysteine by different treatments on rat myocardial ischemia-reperfusion injury. J Pharmacol Sci 2008; 106: 571-577. (Pubitemid 351556235)
11. Hopps E, Noto D, Caimi G, Averna MR,. A novel component of the metabolic syndrome: the oxidative stress. Nutr Metab Cardiovasc Dis 2010; 20: 72-77.
12. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ,. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
13. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ,. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007; 42: 28-42. (Pubitemid 44924323)
14. Hardeland R, Tan DX, Reiter RJ,. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47: 109-126.
15. Korkmaz A, Reiter RJ, Topal T, Manchester LC, Oter S, Tan DX,. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 2009; 15: 43-50.
16. Pandi-Perumal SR, Srinivasan V, Maestroni GJ, Cardinali DP, Poeggeler B, Hardeland R,. Melatonin: natures most versatile biological signal? FEBS J 2006; 273: 2813-2838.
17. Hardeland R, Pandi-Perumal SR, Cardinali DP,. Melatonin. Int J Biochem Cell Biol 2006; 38: 313-316. (Pubitemid 41821880)
18. Brugger P, Marktl W, Herold M,. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 1995; 34: 1408.
19. Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, Kaski JC, Reiter RJ,. Melatonin and circadian biology in human cardiovascular disease. J Pineal Res 2010; 49: 14-22.
20. Sahna E, Acet A, Ozer MK, Olmez E,. Myocardial ischemia-reperfusion in rats: reduction of infarct size by either supplemental physiological or pharmacological doses of melatonin. J Pineal Res 2002; 33: 234-238. (Pubitemid 35252995)
21. Reiter RJ, Tan DX,. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003; 58: 10-19. (Pubitemid 36351618)
22. Lochner A, Genade S, Davids A, Ytrehus K, Moolman JA,. Short- and long-term effects of melatonin on myocardial post-ischemic recovery. J Pineal Res 2006; 40: 56-63.
23. Petrosillo G, Colantuono G, Moro N, et al. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Physiol Heart Circ Physiol 2009; 297: H1487-H1493.
24. Tengattini S, Reiter RJ, Tan DX, Terron MP, Rodella LF, Rezzani R,. Cardiovascular diseases: protective effects of melatonin. J Pineal Res 2008; 44: 16-25. (Pubitemid 350231106)
25. Hussein MR, Ahmed OG, Hassan AF, Ahmed MA,. Intake of melatonin is associated with amelioration of physiological changes, both metabolic and morphological pathologies associated with obesity: an animal model. Int J Exp Pathol 2007; 88: 19-29. (Pubitemid 46145604)
26. Prunet-Marcassus B, Desbazeille M, Bros A, et al. Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology 2003; 144: 5347-5352. (Pubitemid 37476063)
27. Du Toit EF, Smith W, Muller C, et al. Myocardial susceptibility to ischemic-reperfusion injury in a prediabetic model of dietary-induced obesity. Am J Physiol Heart Circ Physiol 2008; 294: H2336-H2343.
28. Du Toit EF, Nabben M, Lochner A,. A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury. Basic Res Cardiol 2005; 100: 346-354. (Pubitemid 40974085)
29. Kannengiesser GJ, Opie LH, Van Der Werff TJ,. Impaired cardiac work and oxygen uptake after reperfusion of regionally ischaemic myocardium. J Mol Cell Cardiol 1979; 11: 197-207. (Pubitemid 9119469)
30. Bradford MM,. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
31. Genade S, Genis A, Ytrehus K, Huisamen B, Lochner A,. Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions. J Pineal Res 2008; 45: 449-458.
32. Akerboom TP, Sies H,. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol 1981; 77: 373-382.
33. Esterbauer H, Striegl G, Puhl H, Rotheneder M,. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989; 6: 67-75. (Pubitemid 19109796)
34. Pryor WA, Castle L,. Chemical methods for the detection of lipid hydroperoxides. Methods Enzymol 1984; 105: 293-299. (Pubitemid 14165389)
35. Jiang ZY, Hunt JV, Wolff SP,. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 1992; 202: 384-389.
36. Jiang ZY, Woollard AC, Wolff SP,. Lipid hydroperoxide measurement by oxidation of Fe2+ in the presence of xylenol orange. comparison with the TBA assay and an iodometric method. Lipids 1991; 26: 853-856.
37. Jentzsch AM, Bachmann H, Furst P, Biesalski HK,. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996; 20: 251-256. (Pubitemid 26021882)
38. Sethi JK, Vidal-Puig AJ,. Thematic review series: adipocyte biology. adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res 2007; 48: 1253-1262. (Pubitemid 47312027)
39. Boden G,. Pathogenesis of type 2 diabetes. Insulin resistance. Endocrinol Metab Clin North Am 2001; 30: 801-815. (Pubitemid 33055264)
40. Morel S, Berthonneche C, Tanguy S, et al. Early pre-diabetic state alters adaptation of myocardial glucose metabolism during ischemia in rats. Mol Cell Biochem 2005; 272: 9-17. (Pubitemid 40867360)
41. Dourmashkin JT, Chang GQ, Gayles EC, et al. Different forms of obesity as a function of diet composition. Int J Obes 2005; 29: 1368-1378. (Pubitemid 41679269)
42. Ahren B,. Plasma leptin and insulin in C57BI/6J mice on a high-fat diet: relation to subsequent changes in body weight. Acta Physiol Scand 1999; 165: 233-240. (Pubitemid 29090273)
43. Havel PJ, Kasim-Karakas S, Mueller W, Johnson PR, Gingerich RL, Stern JS,. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab 1996; 81: 4406-4413. (Pubitemid 26412052)
44. Bartness TJ, Demas GE, Song CK,. Seasonal changes in adiposity: the roles of the photoperiod, melatonin and other hormones, and sympathetic nervous system. Exp Biol Med 2002; 227: 363-376.
45. Tan DX, Manchester LC, Fuentes-Broto L, Paredes SD, Reiter RJ,. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev 2010; doi
46. Peschke E,. Melatonin, endocrine pancreas and diabetes. J Pineal Res 2008; 44: 26-40. (Pubitemid 350231107)
47. Muhlbauer E, Gross E, Labucay K, Wolgast S, Peschke E,. Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose. Eur J Pharmacol 2009; 606: 61-72.
48. She M, Deng X, Guo Z, et al. NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats. Pharmacol Res 2009; 59: 248-253.
49. Contreras-Alcantara S, Baba K, Tosini G,. Removal of melatonin receptor type 1 induces insulin resistance in the mouse. Obesity 2010; 18: 1861-1863.
50. Muhlbauer E, Peschke E,. Evidence for the expression of both the MT1-, and in addition, the MT2-melatonin receptor, in the rat pancreas, islet and beta-cell. J Pineal Res 2007; 42: 105-106. (Pubitemid 44924332)
51. Mulder H, Nagorny CL, Lyssenko V, Groop L,. Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene. Diabetologia 2009; 52: 1240-1249.
52. Picinato MC, Haber EP, Carpinelli AR, Cipolla-Neto J,. Daily rhythm of glucose-induced insulin secretion by isolated islets from intact and pinealectomized rat. J Pineal Res 2002; 33: 172-177.
53. Anhe GF, Caperuto LC, Pereira-Da-Silva M, et al. In vivo activation of insulin receptor tyrosine kinase by melatonin in the rat hypothalamus. J Neurochem 2004; 90: 559-566. (Pubitemid 38989386)
54. Sartori C, Dessen P, Mathieu C, et al. Melatonin improves glucose homeostasis and endothelial vascular function in high-fat diet-fed insulin-resistant mice. Endocrinology 2009; 150: 5311-5317.
55. Wolden-Hanson T, Mitton DR, McCants RL, et al. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 2000; 141: 487-497. (Pubitemid 32250470)
56. Ha E, Yim SV, Chung JH, et al. Melatonin stimulates glucose transport via insulin receptor substrate-1/phosphatidylinositol 3-kinase pathway in C2C12 murine skeletal muscle cells. J Pineal Res 2006; 41: 67-72. (Pubitemid 43980697)
57. Urata Y, Honma S, Goto S, et al. Melatonin induces gamma-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Rad Biol Med 1999; 27: 838-847. (Pubitemid 29454587)
58. Reiter RJ, Tan DX, Osuna G, Gitto E,. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci 2000; 7: 444-458.
59. Dobsak P, Siegelova J, Eicher JC, et al. Melatonin protects against ischemia-reperfusion injury and inhibits apoptosis in isolated working rat heart. Pathophysiology 2003; 9: 179-187. (Pubitemid 37309298)
60. Lee YM, Chen HR, Hsiao G, Sheu JR, Wang JJ, Yen MH,. Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo. J Pineal Res 2002; 33: 72-80. (Pubitemid 34913483)
61. Reiter RJ, Tan DX, Manchester CL, Qi W,. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 2001; 34: 237-256. (Pubitemid 33615836)
62. Sahna E, Parlakpinar H, Turkoz Y, Acet A,. Protective effects of melatonin on myocardial ischemia/reperfusion induced infarct size and oxidative changes. Physiol Res 2005; 54: 491-495. (Pubitemid 41578671)
63. Vincent HK, Powers SK, Stewart DJ, Shanely RA, Demirel H, Naito H,. Obesity is associated with increased myocardial oxidative stress. Int J Obes Relat Metab Disord 1999; 23: 67-74. (Pubitemid 29008401)
64. Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G,. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem 2008; 19: 491-504. (Pubitemid 351952322)
65. Vincent HK, Innes KE, Vincent KR,. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes Metab 2007; 9: 813-839. (Pubitemid 47555204)
66. Anurag P, Anuradha CV,. Metformin improves lipid metabolism and attenuates lipid peroxidation in high fructose-fed rats. Diabetes Obes Metab 2002; 4: 36-42. (Pubitemid 34285265)
67. Bertuglia S, Reiter RJ,. Melatonin reduces ventricular arrhythmias and preserves capillary perfusion during ischemia-reperfusion events in cardiomyopathic hamsters. J Pineal Res 2007; 42: 55-63. (Pubitemid 44924326)
68. Buja LM,. Myocardial ischemia and reperfusion injury. Cardiovasc Pathol 2005; 14: 170-175. (Pubitemid 40977859)
69. Yellon DM, Hausenloy DJ,. Myocardial reperfusion injury. N Engl J Med 2007; 13: 1121-1135.
70. Essop MF, Anna Chan WY, Valle A, Garcia-Palmer FJ, Du Toit EF,. Impaired contractile function and mitochondrial respiratory capacity in response to oxygen deprivation in a rat model of pre-diabetes. Acta Physiol (Oxf) 2009; 197: 289-296.
71. Abete P, Bianco S, Calabrese C, et al. Effects of melatonin in isolated rat papillary muscle. FEBS Lett 1997; 412: 79-85. (Pubitemid 27310004)
72. Arvola L, Bertelsen E, Lochner A, Ytrehus K,. Sustained anti-beta-adrenergic effect of melatonin in guinea pig heart papillary muscle. Scand Cardiovasc J 2006; 40: 37-42. (Pubitemid 43203348)
73. Rodriguez C, Mayo JC, Sainz RM, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9. (Pubitemid 38130283)
74. Bertuglia S, Reiter RJ,. Melatonin reduces microvascular damage and insulin resistance in hamsters due to chronic intermittent hypoxia. J Pineal Res 2009; 46: 307-313.
75. Hausenloy DJ, Yellon DM,. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 2007; 12: 217-234. (Pubitemid 350176695)
76. Paradies G, Petrosillo G, Paradies V, Reiter RJ, Ruggiero FM,. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010; 48: 297-310.